(Q39317009)

11 September 2017

title

Lycorine hydrochloride inhibits metastatic melanoma cell-dominant vasculogenic mimicry (English)

1 reference

11 September 2017

1 reference

1 reference

Ruifang Liu

1

1 reference

11 September 2017

Zhifei Cao

2

1 reference

11 September 2017

Jian Tu

3

1 reference

11 September 2017

Yanyan Pan

4

1 reference

11 September 2017

Bingxue Shang

5

1 reference

11 September 2017

Gaochuan Zhang

6

1 reference

11 September 2017

Meimei Bao

7

1 reference

11 September 2017

Shasha Zhang

8

1 reference

11 September 2017

Ping Yang

9

1 reference

11 September 2017

Quansheng Zhou

10

1 reference

11 September 2017

publication date

1 September 2012

1 reference

Pigment Cell & Melanoma Research

11 September 2017

published in

1 reference

11 September 2017

volume

25

1 reference

11 September 2017

issue

5

1 reference

11 September 2017

page(s)

630-638

1 reference

The integrin antagonist cilengitide activates alphaVbeta3, disrupts VE-cadherin localization at cell junctions and enhances permeability in endothelial cells

11 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-148X.2012.01036.X

Final version of 2009 AJCC melanoma staging and classification

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-148X.2012.01036.X

Endoscopic Resection with Ligation Using a Multi-Band Mucosectomy System in Barrett's Esophagus with High-Grade Dysplasia and Intramucosal Carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-148X.2012.01036.X

Molecular mechanisms and clinical applications of angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-148X.2012.01036.X

Vascular endothelial-cadherin and vascular stability

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-148X.2012.01036.X

The role of adherens junctions and VE-cadherin in the control of vascular permeability

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-148X.2012.01036.X

Antiangiogenic therapy: impact on invasion, disease progression, and metastasis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-148X.2012.01036.X

New drugs in melanoma: it's a whole new world

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-148X.2012.01036.X

Melanoma in 2011: a new paradigm tumor for drug development

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-148X.2012.01036.X

New strategies in metastatic melanoma: oncogene-defined taxonomy leads to therapeutic advances

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-148X.2012.01036.X

Breaking the VE-cadherin bonds.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-148X.2012.01036.X

Blood vessel maturation, vascular phenotype and angiogenic potential in malignant melanoma: one step forward for overcoming anti-angiogenic drug resistance?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-148X.2012.01036.X

Small molecules and targeted therapies in distant metastatic disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-148X.2012.01036.X

Deciphering the signaling events that promote melanoma tumor cell vasculogenic mimicry and their link to embryonic vasculogenesis: role of the Eph receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-148X.2012.01036.X

Improved Survival with Ipilimumab in Patients with Metastatic Melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-148X.2012.01036.X

Amaryllidaceae isocarbostyril alkaloids and their derivatives as promising antitumor agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-148X.2012.01036.X

Lycorine, the main phenanthridine Amaryllidaceae alkaloid, exhibits significant antitumor activity in cancer cells that display resistance to proapoptotic stimuli: an investigation of structure-activity relationship and mechanistic insight

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-148X.2012.01036.X

Lycorine and its derivatives for anticancer drug design.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-148X.2012.01036.X

Jumping the barrier: VE-cadherin, VEGF and other angiogenic modifiers in cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-148X.2012.01036.X

Lycorine induces apoptosis and down-regulation of Mcl-1 in human leukemia cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-148X.2012.01036.X

Vascular channel formation by human melanoma cells in vivo and in vitro: vasculogenic mimicry

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-148X.2012.01036.X

Tumor angiogenesis in melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-148X.2012.01036.X

Identification of a transiently exposed VE-cadherin epitope that allows for specific targeting of an antibody to the tumor neovasculature.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-148X.2012.01036.X

Expression profiling of Galectin-3-depleted melanoma cells reveals its major role in melanoma cell plasticity and vasculogenic mimicry

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-148X.2012.01036.X

Basic and therapeutic aspects of angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-148X.2012.01036.X

The human VE-cadherin promoter is subjected to organ-specific regulation and is activated in tumour angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-148X.2012.01036.X

Kaposi's sarcoma-associated herpesvirus disrupts adherens junctions and increases endothelial permeability by inducing degradation of VE-cadherin

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-148X.2012.01036.X

Amaryllidaceae alkaloids belonging to different structural subgroups display activity against apoptosis-resistant cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-148X.2012.01036.X

VE-cadherin: the major endothelial adhesion molecule controlling cellular junctions and blood vessel formation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-148X.2012.01036.X

Tumor endothelial cell tube formation model for determining anti-angiogenic activity of a tRNA synthetase cytokine

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-148X.2012.01036.X

Orthogonal use of a human tRNA synthetase active site to achieve multifunctionality

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-148X.2012.01036.X

Effects of Angiogenesis Inhibitors on Vascular Network Formation by Human Endothelial and Melanoma Cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-148X.2012.01036.X

Phase I/II trial of tremelimumab in patients with metastatic melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-148X.2012.01036.X

10.1111/J.1755-148X.2012.01036.X

21 January 2018

Identifiers

DOI

1 reference

11 September 2017

1 reference